AbbVie Inc. (ABBV) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Tue January 19th, 2021

- 14:05
  AnalysisInvest Like A Billionaire With High Yield: THWSeeking Alpha

Mon January 18th, 2021

- 15:35
  AnalysisAbbVie: Undervalued Dividend Aristocrat Offering A 4.77% YieldSeeking Alpha

Fri January 15th, 2021

- 12:00
  Analysis3 Green Flags for AbbVie in 2021 and 1 Red FlagThe Motley Fool

Thu January 14th, 2021

- 06:31
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisMy Dividend Portfolio: December 2020 Update - 97 Holdings, 46 Buys, 5 Forced SellsSeeking Alpha

Wed January 13th, 2021

Tue January 12th, 2021

- 11:25
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisGuideNicholas Ward's Dividend Growth Portfolio: 2020 ReviewSeeking Alpha

Mon January 11th, 2021

- 03:11
  AnalysisDividend Diligence On AbbVie With Seeking AlphaSeeking Alpha
- 01:43
  AnalysisAbbVie Looks Attractive Despite HeadwindsSeeking Alpha

Sat January 9th, 2021

Fri January 8th, 2021

- 19:01
  AnalysisMy Dividend Growth Portfolio Update: Hindsight Is 2020Seeking Alpha
- 13:47
  AnalysisAbbVie's (ABBV) Skyrizi Succeeds in Crohn's Disease StudiesZacks

Thu January 7th, 2021

- 18:38
  Analysis8 Dividend Increases To Start 2021Seeking Alpha

Wed January 6th, 2021

- 17:10
  EarningsAnalysisWhy AbbVie (ABBV) Could Beat Earnings Estimates AgainZacks
- 15:14
  AnalysisAbbVie's (ABBV) Skyrizi Succeeds in Psoriatic Arthritis StudiesZacks
- 14:15
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisBerkshire Hathaway Q4 2020 Earnings And Book Value EstimatesSeeking Alpha

Tue January 5th, 2021

- 22:41
  AnalysisGuide11 Years Of Dividend Growth Investing - A Portfolio ReviewSeeking Alpha
- 21:20
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisMy Dividend Growth Portfolio - Q4 2020 SummarySeeking Alpha

Mon January 4th, 2021

- 16:17
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Analysis5-Year Plan, Update #5 - The Grand FinaleSeeking Alpha
- 13:05
  AnalysisAbbVie's Fair Value Is At Least $147 Per ShareSeeking Alpha

Thu December 31st, 2020

- 18:40
  AnalysisGuideTop 10 Undervalued High-Yield Income Stocks For 2021Seeking Alpha

Wed December 30th, 2020

- 16:10
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: Johnson & Johnson, NVIDIA, Cisco, AbbVie and SonyZacks
- 11:12
  AnalysisGuide2 Top Picks - Safe High Dividend Biotechs For 2021Seeking Alpha
- 04:13
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisI Replaced A Jumbo CD With This Eclectic Portfolio Of Value-Conscious Dividend-Paying StocksSeeking Alpha
- 00:19
  AnalysisUndervalued Pharmaceutical Dividends For The New YearSeeking Alpha

Tue December 29th, 2020

Mon December 28th, 2020

- 21:41
  Analysis3 A+ Stocks To Buy And Hold ForeverSeeking Alpha
- 14:47
  AnalysisAbbVie (ABBV) Outperforms Industry Year to Date: Here's WhyZacks

Sun December 27th, 2020

- 20:04
  IPOAnalysisDigestWeek In Review: Beijing's Jacobio Completes $174 Million Hong Kong IPOSeeking Alpha

Wed December 23rd, 2020

- 20:39
  AnalysisCuris Inc.: Understanding CA-4948 And IRAK-4 InhibitionSeeking Alpha
- 18:12
  Press ReleasesAnalysisConstruction Partners, Surgery Partners, Qualcomm, AbbVie and Garmin as Zacks Bull and Bear of the DayZacks

Tue December 22nd, 2020

Mon December 21st, 2020

- 20:37
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisDividend Income Update: November 2020Seeking Alpha

SPY$379.691.1%

QQQ$317.861.9%

DOW$57.550.42%

APHA$13.387.7%

GME$38.839.4%

TLRY$20.041.7%

SPY$379.691.1%

QQQ$317.861.9%

DOW$57.550.42%

APHA$13.387.7%

GME$38.839.4%

TLRY$20.041.7%

About Developer Contact